| Target and Pathway |
Top |
| Target(s) |
PRKACA messenger RNA (PRKACA mRNA) |
Target Info
|
. |
[1] |
|
KEGG Pathway
|
MAPK signaling pathway
|
|
Ras signaling pathway
|
|
Calcium signaling pathway
|
|
cAMP signaling pathway
|
|
Chemokine signaling pathway
|
|
Oocyte meiosis
|
|
Apoptosis
|
|
Adrenergic signaling in cardiomyocytes
|
|
Vascular smooth muscle contraction
|
|
Wnt signaling pathway
|
|
Hedgehog signaling pathway
|
|
Gap junction
|
|
Platelet activation
|
|
Circadian entrainment
|
|
Long-term potentiation
|
|
Retrograde endocannabinoid signaling
|
|
Glutamatergic synapse
|
|
Cholinergic synapse
|
|
Serotonergic synapse
|
|
GABAergic synapse
|
|
Dopaminergic synapse
|
|
Olfactory transduction
|
|
Taste transduction
|
|
Inflammatory mediator regulation of TRP channels
|
|
Insulin signaling pathway
|
|
Insulin secretion
|
|
GnRH signaling pathway
|
|
Ovarian steroidogenesis
|
|
Progesterone-mediated oocyte maturation
|
|
Estrogen signaling pathway
|
|
Melanogenesis
|
|
Thyroid hormone synthesis
|
|
Thyroid hormone signaling pathway
|
|
Oxytocin signaling pathway
|
|
Glucagon signaling pathway
|
|
Regulation of lipolysis in adipocytes
|
|
Renin secretion
|
|
Endocrine and other factor-regulated calcium reabsorption
|
|
Vasopressin-regulated water reabsorption
|
|
Salivary secretion
|
|
Gastric acid secretion
|
|
Bile secretion
|
|
Parkinson's disease
|
|
Prion diseases
|
|
Cocaine addiction
|
|
Amphetamine addiction
|
|
Morphine addiction
|
|
Alcoholism
|
|
Vibrio cholerae infection
|
|
Amoebiasis
|
|
HTLV-I infection
|
|
Epstein-Barr virus infection
|
|
Pathways in cancer
|
|
Viral carcinogenesis
|
|
Proteoglycans in cancer
|
|
Dilated cardiomyopathy
|
|
Panther Pathway
|
Endothelin signaling pathway
|
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
|
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction
|
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
|
Metabotropic glutamate receptor group III pathway
|
|
Metabotropic glutamate receptor group II pathway
|
|
Metabotropic glutamate receptor group I pathway
|
|
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
|
|
5HT1 type receptor mediated signaling pathway
|
|
Beta1 adrenergic receptor signaling pathway
|
|
Beta2 adrenergic receptor signaling pathway
|
|
Histamine H2 receptor mediated signaling pathway
|
|
GABA-B receptor II signaling
|
|
Dopamine receptor mediated signaling pathway
|
|
Enkephalin release
|
|
Nicotine pharmacodynamics pathway
|
|
CCKR signaling map ST
|
|
Pathwhiz Pathway
|
Muscle/Heart Contraction
|
|
Pathway Interaction Database
|
GMCSF-mediated signaling events
|
|
LPA4-mediated signaling events
|
|
Signaling events regulated by Ret tyrosine kinase
|
|
LKB1 signaling events
|
|
Thromboxane A2 receptor signaling
|
|
SHP2 signaling
|
|
Signaling events mediated by HDAC Class I
|
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
|
Glucocorticoid receptor regulatory network
|
|
ErbB2/ErbB3 signaling events
|
|
IL3-mediated signaling events
|
|
Syndecan-1-mediated signaling events
|
|
Retinoic acid receptors-mediated signaling
|
|
Hedgehog signaling events mediated by Gli proteins
|
|
VEGFR1 specific signals
|
|
Calcium signaling in the CD4+ TCR pathway
|
|
Signaling events mediated by VEGFR1 and VEGFR2
|
|
Syndecan-2-mediated signaling events
|
|
Aurora A signaling
|
|
Class I PI3K signaling events mediated by Akt
|
|
Alpha4 beta1 integrin signaling events
|
|
Reactome
|
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
|
|
PKA activation
|
|
PKA activation in glucagon signalling
|
|
DARPP-32 events
|
|
Regulation of PLK1 Activity at G2/M Transition
|
|
Loss of Nlp from mitotic centrosomes
|
|
Recruitment of mitotic centrosome proteins and complexes
|
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
|
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
|
|
Regulation of insulin secretion
|
|
Vasopressin regulates renal water homeostasis via Aquaporins
|
|
VEGFA-VEGFR2 Pathway
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
Degradation of GLI1 by the proteasome
|
|
Degradation of GLI2 by the proteasome
|
|
Hedgehog 'off' state
|
|
Anchoring of the basal body to the plasma membrane
|
|
CD209 (DC-SIGN) signaling
|
|
MAPK6/MAPK4 signaling
|
|
Gluconeogenesis
|
|
Factors involved in megakaryocyte development and platelet production
|
|
WikiPathways
|
SIDS Susceptibility Pathways
|
|
Hypothetical Network for Drug Addiction
|
|
Calcium Regulation in the Cardiac Cell
|
|
Endochondral Ossification
|
|
MAPK Signaling Pathway
|
|
G Protein Signaling Pathways
|
|
Myometrial Relaxation and Contraction Pathways
|
|
IL-3 Signaling Pathway
|
|
Mesodermal Commitment Pathway
|
|
Human Complement System
|
|
DAG and IP3 signaling
|
|
Regulation of Water Balance by Renal Aquaporins
|
|
Dopamine metabolism
|
|
Regulation of Microtubule Cytoskeleton
|
|
FSH signaling pathway
|
|
miRs in Muscle Cell Differentiation
|
|
SREBP signalling
|
|
Opioid Signalling
|
|
Mitotic G2-G2/M phases
|
|
Integration of energy metabolism
|
|
Factors involved in megakaryocyte development and platelet production
|
|
Nicotine Activity on Dopaminergic Neurons
|
